Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MME | P08473 | 2/20 | 0.48 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | CA4 | P22748 | 1/20 | 0.39 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.36 |
| ▸ | ADRA2B | P18089 | 2/20 | 0.36 |
| ▸ | ADRA2C | P18825 | 2/20 | 0.36 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | MMP1 | P03956 | 4/20 | 0.34 |
| ▸ | MMP3 | P08254 | 3/20 | 0.34 |
| ▸ | USP2 | O75604 | 1/20 | 0.33 |
| ▸ | LTA4H | P09960 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2451834 | 0.92 | MME (0.41) | MMESMN1; SMN2MMP1MMP3 | |
| SCHEMBL2864322 | 0.90 | MME (0.40) | MMEMMP1MMP3 | |
| SCHEMBL2855042 | 0.89 | MME (0.40) | MMEMMP1MMP3 | |
| SCHEMBL2449975 | 0.88 | MME (0.45) | MMECA1CA2CA4ADRA2A | |
| SCHEMBL2457380 | 0.88 | CXCR2 (0.37) | MMESMN1; SMN2MMP1MMP3USP2 | |
| SCHEMBL2453323 | 0.82 | MMP1 (0.38) | MMEMMP1MMP3USP2LTA4H | |
| SCHEMBL2448444 | 0.80 | MME (0.39) | MMEMMP1 | |
| SCHEMBL2863809 | 0.79 | MME (0.38) | MME | |
| SCHEMBL2450421 | 0.79 | MMP1 (0.36) | MMP1MMP3USP2LTA4H | |
| SCHEMBL2866093 | 0.78 | USP2 (0.53) | SMN1; SMN2USP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115556441-B | Decorative film and method for producing decorative molded article using same | 日本聚丙烯株式会社 | 2025-04-11 | — | — | CN | disclosed |
| CN-115556446-A | Decorative film and method for producing decorative molded body using same | 日本聚丙烯株式会社 | 2023-01-03 | — | — | CN | disclosed |
| CN-115556441-A | Decorative film and method for producing decorative molded body using same | 日本聚丙烯株式会社 | 2023-01-03 | — | — | CN | disclosed |
| US-20200384678-A1 | DECORATIVE FILM AND METHOD FOR MANUFACTURING DECORATIVE MOLDED ARTICLE USING SAME | JAPAN POLYPROPYLENE CORPORATION (JP) | 2020-12-10 | — | — | US | disclosed |
| EP-3715092-A1 | DECORATIVE FILM AND METHOD FOR MANUFACTURING DECORATIVE MOLDED ARTICLE USING SAME | Japan Polypropylene Corporation (JP) | 2020-09-30 | — | — | EP | disclosed |
| EP-2862883-B1 | METHOD FOR PRODUCING NUCLEATOR MASTERBATCH | ADEKA CORP (JP) | 2019-09-25 | — | — | EP | disclosed |
| US-9243127-B2 | Method for producing nucleator masterbatch | ADEKA CORPORATION (JP) | 2016-01-26 | — | — | US | disclosed |
| US-20150152248-A1 | METHOD FOR PRODUCING NUCLEATOR MASTERBATCH | ADEKA CORPORATION (JP) | 2015-06-04 | — | — | US | disclosed |
| EP-2862883-A1 | METHOD FOR PRODUCING NUCLEATOR MASTERBATCH | Adeka Corporation (JP) | 2015-04-22 | — | — | EP | disclosed |
| US-8492468-B2 | Polypropylene resin composition | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2013-07-23 | — | — | US | disclosed |
| EP-2096137-B1 | NOVEL POLYOLEFIN RESIN COMPOSITION AND MOLDED RESIN OBTAINED THEREFROM | NEW JAPAN CHEM CO LTD (JP) | 2011-09-14 | — | — | EP | disclosed |
| US-7723413-B2 | Method and composition for control of crystallization rate of polyolefin resin, resin composition and resin molding | NEW JAPAN CHEMICAL CO., LTD. (JP) | 2010-05-25 | — | — | US | disclosed |
| US-7696380-B2 | Such as 1,2,3-propanetricarboxylic acid tris(trans-2-methylcycloheylamide; nucleation | NEW JAPAN CHEMICAL CO., LTD. (JP) | 2010-04-13 | — | — | US | disclosed |
| EP-1715000-B1 | METHOD AND COMPOSITION FOR CONTROL OF CRYSTALLIZATION RATE OF POLYOLEFIN RESIN, RESIN COMPOSITION AND RESIN MOLDING | NEW JAPAN CHEM CO LTD (JP) | 2010-03-10 | — | — | EP | disclosed |
| US-20100016491-A1 | NOVEL POLYOLEFIN RESIN COMPOSITION AND MOLDED RESIN OBTAINED THEREFROM | NEW JAPAN CHEMICAL CO., LTD. (JP) | 2010-01-21 | — | — | US | disclosed |
| EP-2096137-A1 | NOVEL POLYOLEFIN RESIN COMPOSITION AND MOLDED RESIN OBTAINED THEREFROM | New Japan Chemical Co., Ltd. (JP) | 2009-09-02 | — | — | EP | disclosed |
| US-20070142514-A1 | Method and composition for control of crystallization rate of polyolefin resin, resin composition and resin molding | NEW JAPAN CHEMICAL CO., LTD. (JP) | 2007-06-21 | — | — | US | disclosed |
| US-20070066687-A1 | Amide-based compound, polyolefin resin composition and molded product | NEW JAPAN CHEMICAL CO., LTD. (JP) | 2007-03-22 | — | — | US | disclosed |
| EP-1715000-A1 | METHOD AND COMPOSITION FOR CONTROL OF CRYSTALLIZATION RATE OF POLYOLEFIN RESIN, RESIN COMPOSITION AND RESIN MOLDING | NEW JAPAN CHEMICAL CO.,LTD. (JP) | 2006-10-25 | — | — | EP | disclosed |
| EP-1674447-A1 | AMIDES, POLYOLEFIN RESIN COMPOSITIONS, AND MOLDINGS | NEW JAPAN CHEMICAL CO.,LTD. (JP) | 2006-06-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070066687-A1 | Amide-based compound, polyolefin resin composition and molded product | NAA50, ARG1, RFT1 | MME 3683/4885CA1 1090/4885CA2 3440/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.